Neurogene Inc.
(NGNE)
undefined
undefined%
At close: undefined
23.00
-1.71%
After-hours Dec 13, 2024, 06:05 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 |
Revenue | - | - | - | - | - | 25.00M | - | - |
Cost of Revenue | 3.26M | 3.20M | 2.28M | 1.82M | 340.00K | - | - | - |
Gross Profit | -3.26M | -3.20M | -2.28M | -1.82M | -340.00K | 25.00M | - | - |
Operating Income | -55.58M | -56.52M | -50.53M | -41.55M | -24.44M | -23.52M | -51.12M | -37.65M |
Interest Income | 2.95M | 1.34M | 17.00K | 490.00K | 1.54M | 1.56M | 998.00K | 619.00K |
Pretax Income | -36.32M | -55.19M | -50.52M | -33.28M | -69.44M | -31.59M | -50.18M | -37.00M |
Net Income | -36.32M | -55.19M | -50.52M | -33.28M | -69.44M | -31.59M | -50.18M | -37.00M |
Selling & General & Admin | 11.19M | 9.01M | 8.27M | 15.39M | 17.79M | 15.73M | 14.85M | 9.26M |
Research & Development | 44.39M | 47.51M | 42.26M | 24.34M | 6.32M | 32.79M | 36.27M | 28.38M |
Other Expenses | -28.00K | -7.00K | - | - | - | - | - | - |
Operating Expenses | 55.58M | 56.52M | 50.53M | 39.73M | 24.10M | 48.52M | 51.12M | 37.65M |
Interest Expense | 12.00K | 2.00K | - | - | 1K | 4.00K | 4.00K | 1K |
Selling & Marketing Expenses | - | - | - | - | - | - | - | - |
Cost & Expenses | 55.58M | 56.52M | 50.53M | 41.55M | 24.44M | 48.52M | 51.12M | 37.65M |
Income Tax | - | -5.00K | 17.00K | -1 | 168.14K | - | -1 | -1 |
Shares Outstanding (Basic) | 12.82M | 12.82M | 55.04M | 51.83M | 27.03M | 23.52M | 23.45M | 18.89M |
Shares Outstanding (Diluted) | 12.82M | 12.82M | 55.04M | 51.83M | 27.03M | 23.52M | 23.45M | 18.89M |
EPS (Basic) | -2.83 | -4.3 | -0.92 | -0.64 | -2.57 | -1.34 | -2.14 | -1.96 |
EPS (Diluted) | -2.83 | -4.3 | -0.92 | -0.64 | -2.57 | -1.34 | -2.14 | -1.96 |
EBITDA | -52.29M | -51.99M | -49.59M | -31.46M | -69.10M | -31.58M | -50.18M | -37.00M |
Depreciation & Amortization | 3.30M | 3.20M | 2.28M | 1.82M | 340.00K | - | 1.00 | 1.00 |